Correlation Between HealthEquity and 10X Genomics
Can any of the company-specific risk be diversified away by investing in both HealthEquity and 10X Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HealthEquity and 10X Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HealthEquity and 10X Genomics, you can compare the effects of market volatilities on HealthEquity and 10X Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HealthEquity with a short position of 10X Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HealthEquity and 10X Genomics.
Diversification Opportunities for HealthEquity and 10X Genomics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HealthEquity and 10X is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding HealthEquity and 10X Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 10X Genomics and HealthEquity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HealthEquity are associated (or correlated) with 10X Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 10X Genomics has no effect on the direction of HealthEquity i.e., HealthEquity and 10X Genomics go up and down completely randomly.
Pair Corralation between HealthEquity and 10X Genomics
Considering the 90-day investment horizon HealthEquity is expected to generate 0.47 times more return on investment than 10X Genomics. However, HealthEquity is 2.12 times less risky than 10X Genomics. It trades about 0.2 of its potential returns per unit of risk. 10X Genomics is currently generating about -0.06 per unit of risk. If you would invest 7,910 in HealthEquity on November 1, 2024 and sell it today you would earn a total of 2,970 from holding HealthEquity or generate 37.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HealthEquity vs. 10X Genomics
Performance |
| Timeline |
| HealthEquity |
| 10X Genomics |
HealthEquity and 10X Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HealthEquity and 10X Genomics
The main advantage of trading using opposite HealthEquity and 10X Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HealthEquity position performs unexpectedly, 10X Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 10X Genomics will offset losses from the drop in 10X Genomics' long position.| HealthEquity vs. Ollies Bargain Outlet | HealthEquity vs. Appfolio | HealthEquity vs. Grand Canyon Education | HealthEquity vs. Globus Medical |
| 10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |